Letermovir | Interleukin Related interleukin-related.com

Product Name :
Letermovir

Search keywords :
Letermovir

drugId :
null

Target Vo:
Human cytomegalovirus tripartite terminas

Target Vo Short Name :
HCMV terminas

Moa_Name:
Human cytomegalovirus tripartite terminas inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Aicuris

Active Company_Name :
Ljubljana University Medical Centre

Active Indication_Name:
Cytomegalovirus Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
eIF5A Antibody
CD44 Antibody
PDGFR alpha Antibody: PDGFR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 123 kDa, targeting to PDGFR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts